Stem cells in treatment of crohn's disease: Recent advances and future directions

Background and aim: Crohn's disease (CD) is an inflammatory bowel disease that can affect any part of the in-testine. There is currently no recognized cure for CD because its cause is unknown. One of the modern ap-proaches that have been suggested for the treatment of CD and other inflammatory-based disorders is cell therapy.Methods: Search terms were stem cell therapy, CD, adipose-derived stem cells, mesenchymal stem cells, and fistula. Of 302 related studies, we removed duplicate and irrelevant papers and identified the ones with proper information related to our scope of the research by reviewing all the abstracts and categorizing each study into the proper section.Results and conclusion: Nowadays, stem cell therapy is widely implied in treating CD. Although mesenchymal and adipose-derived tissue stem cells proved to be safe in treating Crohn's-associated fistula, there are still debates on an optimal protocol to use. Additionally, there is still a lack of evidence on the efficacy of stem cell therapy for intestinal involvement of CD. Future investigations should focus on preparing a standard protocol as well as luminal stem cell therapy in patients.